There is the registration on new IP coming out of the phase 2 in oral Nadolol.
Glass will be presenting results as soon as the further results are in and there will be academic interest.
Zafirlukast could hit a development milestone with toxicity testing as could inhaled Nadolol .
Partnering is of course the only way forward for any of these projects . The company is almost out of funds .
Anybody else?
What's next, page-2
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.12M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $60.87K | 12.17M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2874813 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 9117312 | 14 |
View Market Depth
| Last trade - 10.05am 27/05/2024 (20 minute delay) ? |
| IVX (ASX) Chart |